Skip to Content
Merck
  • A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.

A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.

Toxicology and applied pharmacology (2015-10-13)
Cristina Avonto, Amar G Chittiboyina, Diego Rua, Ikhlas A Khan
ABSTRACT

Skin sensitization is an important toxicological end-point in the risk assessment of chemical allergens. Because of the complexity of the biological mechanisms associated with skin sensitization, integrated approaches combining different chemical, biological and in silico methods are recommended to replace conventional animal tests. Chemical methods are intended to characterize the potential of a sensitizer to induce earlier molecular initiating events. The presence of an electrophilic mechanistic domain is considered one of the essential chemical features to covalently bind to the biological target and induce further haptenation processes. Current in chemico assays rely on the quantification of unreacted model nucleophiles after incubation with the candidate sensitizer. In the current study, a new fluorescence-based method, 'HTS-DCYA assay', is proposed. The assay aims at the identification of reactive electrophiles based on their chemical reactivity toward a model fluorescent thiol. The reaction workflow enabled the development of a High Throughput Screening (HTS) method to directly quantify the reaction adducts. The reaction conditions have been optimized to minimize solubility issues, oxidative side reactions and increase the throughput of the assay while minimizing the reaction time, which are common issues with existing methods. Thirty-six chemicals previously classified with LLNA, DPRA or KeratinoSens™ were tested as a proof of concept. Preliminary results gave an estimated 82% accuracy, 78% sensitivity, 90% specificity, comparable to other in chemico methods such as Cys-DPRA. In addition to validated chemicals, six natural products were analyzed and a prediction of their sensitization potential is presented for the first time.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DL-Lactic acid, 85 % (w/w), syrup
Sigma-Aldrich
β-Propiolactone, Grade II, ≥90%
Sigma-Aldrich
Benzyl benzoate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Safranal, ≥90%, stabilized
Sigma-Aldrich
Maleimide, 99%
Sigma-Aldrich
Citral, natural, ≥96%, FCC, FG
Sigma-Aldrich
3,4-Dihydroxy-3-cyclobutene-1,2-dione, ≥99.0% (HPLC)
Sigma-Aldrich
1,5-Diazabicyclo[4.3.0]non-5-ene, 98%
Sigma-Aldrich
1-Bromobutane, ReagentPlus®, 99%
Sigma-Aldrich
cis-6-Nonenal, ≥95%, FG
Sigma-Aldrich
trans-Cinnamaldehyde, ≥99%
Sigma-Aldrich
trans-2-Hexen-1-al, ≥95%, FCC, FG
Sigma-Aldrich
Cystamine dihydrochloride, BioXtra
Sigma-Aldrich
Benzyl benzoate, meets USP testing specifications
Sigma-Aldrich
Benzyl benzoate, natural, ≥99%, FG
Sigma-Aldrich
Cystamine dihydrochloride, 96%
Sigma-Aldrich
trans-2-Hexen-1-al, 98%
Sigma-Aldrich
Cinnamyl alcohol, 98%
Sigma-Aldrich
trans-Cinnamaldehyde, 97%
Sigma-Aldrich
trans-Cinnamaldehyde, FCC, FG
Sigma-Aldrich
Lactic acid solution, ACS reagent, ≥85%
Sigma-Aldrich
Cinnamyl alcohol, ≥98%, FG
Sigma-Aldrich
Citral, 95%
Sigma-Aldrich
Citral, mixture of cis and trans, ≥96%, FG
Sigma-Aldrich
Benzyl benzoate, ≥99%, FCC, FG
Sigma-Aldrich
Costunolide, ≥97% (HPLC)
Sigma-Aldrich
Dansyl chloride, BioReagent, suitable for amino acid labeling, powder and chunks, ≥99% (HPLC)
Sigma-Aldrich
Lactic acid, meets USP testing specifications
Sigma-Aldrich
Coumarin, ≥99% (HPLC)
Sigma-Aldrich
Benzaldehyde, ReagentPlus®, ≥99%